Showing results (1301-1310 of 6,507) with videos related to

Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Species-specific TNF induction of thymocyte proliferationM J Ehrke, R L Ho, K Hori
Cancer Immunology, Immunotherapy : CII|January 1, 1988
Propagation of cytotoxic effectors from chronic myeloid leukemia patients and cloning of cytotoxic T cellsR Somasundaram, S H Advani, S G Gangal
Cancer Immunology, Immunotherapy : CII|June 26, 2020
A single-valent long-acting human CD47 antagonist enhances antibody directed phagocytic activitiesFenglan Wu, Yangsheng Qiu, Yuhong Xu
Cancer Immunology, Immunotherapy : CII|April 26, 2021
Blood tumor mutation burden can predict the clinical response to immune checkpoint inhibitors in advanced non-small cell lung cancer patientsXi Chen, Liangjie Fang, Yanping Zhu, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1986
Optimization and limitations of systemic treatment of murine melanoma metastases with liposomes containing muramyl tripeptide phosphatidylethanolamineI J Fidler
Cancer Immunology, Immunotherapy : CII|April 15, 2021
Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitationsOndrej Uher, Veronika Caisova, Lucie Padoukova, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2021
Tumor morphology and location associate with immune cell composition in pleomorphic sarcomaRosanna L Wustrack, Evans Shao, Joey Sheridan, et al.
Cancer Immunology, Immunotherapy : CII|April 14, 2021
Complete rejection of large established breast cancer by local immunochemotherapy with T cell activation against neoantigensJunxia Gao, Xianlin Yuan, Jia Yuan, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2012
The role of gamma interferon in DNA vaccine-induced tumor immunity targeting simian virus 40 large tumor antigenJoel F Aldrich, Michael H Shearer, Devin B Lowe, et al.
Cancer Immunology, Immunotherapy : CII|September 19, 2012
Pretreatment neutrophil to lymphocyte ratio is associated with response to therapy and prognosis of advanced non-small cell lung cancer patients treated with first-line platinum-based chemotherapyYanwen Yao, Dongmei Yuan, Hongbing Liu, et al.
Pageof 651